It was a pleasure to meet Professor Ivana Isgum, Amsterdam University Medical Center, at the ECCO 2019 European Cancer Summit in Brussels to discuss her perspective on the very important topic of artificial Intelligence, its impact on cancer care and what we can expect in the future.
1. How extensively is artificial intelligence (AI) currently used in cancer care? Are there any cancer treatment centres using AI, or is it a future tool for cancer management? (0:10)
2. Is there any clinical evidence showing that AI can speed diagnosis and/or improve outcomes in cancer? (00:38)
3. What current and future roles might AI have in cancer diagnosis and screening and is this better than traditional methods or should it be used alongside them? Are there some cancer types that are more suitable for AI involvement? (1:34)
4. Does AI have a current or future role in designing personalised treatment regimens and monitoring responses? (2:30)
5. Can AI use existing clinical trial and real-world data to better detect cancers and recommend optimal care? (3:30)
Ivana Isgum has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European Cancer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
Share this Video
Related Videos In Policy
Mark Lawler, European Cancer Summit 2022: The ECO-ASCO Special Network
The impact of the Russian invasion on Ukraine and how this has impacted clinical trials and cancer care in Europe. The Special Network on the Impact of the War in Ukraine on Cancer was established by ECO Board and ASCO soon after the war started, and now has representatives of over 300 organisations. In this […]
Mark Lawler, European Cancer Summit, 2022: What is the European Cancer Pulse?
Professor Mark Lawler (Queen’s University Belfast) summarizes the European Cancer Pulse, an exciting new tool that brings together data from 34 European countries and helps determine cancer care disparities on cancer burden, research spending, prevention efforts, early detection, diagnosis and treatment access, survivorship, impact of social determinants and much more. For more information, click here. […]
Mark Lawler, European Cancer Summit 2022: The European Groundshot
The European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission is a unique imitative launched this year aims to identify the challenges in cancer care in Europe. The COVID-19 pandemic has had a significant impact on cancer diagnosis and halted many ongoing clinical trials. In this video, Professor Mark Lawler (Queen’s University Belfast) describes […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!